Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin.

This article discusses the use of the hollow-fibre system for tuberculosis (HFS-TB) in drug development. The study aims to optimize and standardize operational procedures of the HFS-TB. The researchers conducted experiments to analyze the impact of various variables, such as bacterial adaptation time, cartridge size, and bacterial strain, on the effectiveness of moxifloxacin, a drug used to treat tuberculosis. The findings highlight the need for standardization and proper reporting of critical parameters in HFS-TB studies to improve the reliability and clinical relevance of the results. [Extracted from the article]